Clinician's Roundtable

Guest: Shari Lipner, MD Nail psoriasis requires a patient-centric approach that balances targeted treatments with realistic expectations. Dr. Shari Lipner shares expert insights on intralesional steroids, topical therapies, and advanced systemic options to manage this challenging condition. Dr. Lipner is an Associate Professor of Clinical Dermatology and the Director of the Nail Center at Weill Cornell Medicine.

Guest: Shari Lipner, MD A combination of clinical evaluation, histopathology, and emerging imaging techniques can help diagnose nail psoriasis. Hear from Dr. Shari Lipner, Associate Professor of Clinical Dermatology at Weill Cornell Medicine, as she explains common characteristics of nail psoriasis and best practices for diagnosing it and distinguishing it from similar diseases.

Guest: Atul A. Deodhar, MD, MRCP Despite feeling some symptom relief with treatment, patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis often experience persistent unmet needs. Residual pain, fatigue, and uncertainty about whether current therapies alter disease progression and outcomes are a few of the challenges that remain unaddressed, emphasizing the need for improved understanding and management of these conditions. Learn about how these difficulties impact patients with Dr. Atul Deodhar, Professor of Medicine and Medical Director of Rheumatology Clinics at Oregon Health & Science University.

Guest: Robert Gniadecki, MD For patients with psoriasis, the most effective therapy is not always accessible. Considering patient-specific factors, including overall health, can help create a holistic treatment plan. Tune in to hear from Dr. Robert Gniadecki, Professor and Director of the Division of Dermatology at the University of Alberta, as he discusses best practices for tailoring psoriasis management.

Guest: Daniel M. Klufas, MD Early diagnosis and prompt intervention in hidradenitis suppurativa patients are essential to preventing long-term impacts. With emerging treatments on the horizon, the future of hidradenitis suppurativa care is promising. Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco, provides insight into the future of diagnosis and treatment.

Guest: Daniel M. Klufas, MD Hidradenitis suppurativa is a chronic skin condition characterized by painful abscesses, sinus tracts, and immune dysregulation. Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco, explains the symptoms, impacts, and unmet needs associated with the disease.

Guest: Daniel M. Klufas, MD For patients with hidradenitis suppurativa, treatment varies by stage. Topicals, antibiotics, biologics, and procedural interventions can all play a role in management depending on symptoms and severity. Learn more as Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco discusses current options and best practices for optimal care.

Host: Raj Chovatiya, MD, PhD Here to share a glimpse into where the dermatology field might be headed based on updates from the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.

Host: Raj Chovatiya, MD, PhD Here to share his insights on the key themes and topics covered at the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.

Host: Raj Chovatiya, MD, PhD In light of the Maui Derm 2025 conference, Dr. Raj Chovatiya is here to discuss the most significant updates in the dermatology field that helped define 2024. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.